Completion of £16m medical centre 'firmly in sight'
The Trowbridge Integrated Care Centre in Wiltshire has been described as a "state-of-the-art health and care facility" and is due to open to patients early next year.
The site will become the location for the minor injury unit and X-ray department that are currently based within the nearby Trowbridge Community Hospital.
Interim executive lead for cancer, planned care and community, Caroline Holmes, said: "The building work is well under way, the finish line is firmly in sight, and local people can now see their new integrated care centre really begin to take shape.
Using the latest green technology, such as solar panels and heat pumps, the centre is designed to be fully self-sufficient and net zero carbon.
Representatives from Bath and North East Somerset, Swindon and Wiltshire Integrated Care Board (ICB) marked the "milestone" occasion on the recently installed roof.
They were joined by the Mayor of Trowbridge, along with a number of NHS colleagues who will soon call the new centre home.
Ms Holmes thanked those who had helped bring the new centre to life.
She added: "When the very first spades went in the ground, it was difficult to picture how a brand new health and care facility could emerge from what was essentially a very muddy field. Yet, here we are."
The new centre is set to be a "flagship location" for local health and care, with teams from many different organisations, including HCRG Care Group, Avon and Wiltshire Mental Health Partnership and the Royal United Hospital, working together under one roof.
Follow BBC Wiltshire on Facebook, X and Instagram. Send your story ideas to us on email or via WhatsApp on 0800 313 4630.
New £16m health centre given go ahead
Bath and North East Somerset, Swindon and Wiltshire ICB
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
32 minutes ago
- Medscape
Brain Changes Linked to Dementia Found in Ex-Rugby Players
Two studies led by researchers at Imperial College London (ICL) have identified structural brain changes and blood biomarkers linked to dementia in former professional rugby players. The findings provide the first prospective evidence of physical brain and blood abnormalities in this group. Previous research had already shown that elite rugby players face a higher risk of neurodegenerative diseases later in life. The studies examined links between repeated head impacts in rugby and conditions such as Alzheimer's disease and chronic traumatic encephalopathy (CTE). Post-mortem examinations of former players have shown neuropathologies consistent with repetitive brain trauma. Traumatic brain injury, already a known risk factor for neurodegeneration, contributes to an estimated 3%-15% of dementia cases in the general population. While recent advances in fluid and imaging biomarkers have transformed dementia diagnosis, these techniques have not been systematically applied to rugby players previously exposed to multiple head impacts. Study Cohort and Methods The research involved 200 ex-professional rugby players aged 30-61 (median age, 44), all of whom had self-referred with brain health concerns but had no dementia diagnosis at baseline. At least one previous concussion while playing was reported by 193 (96.5%) of the former players, with a median of seven concussions. The rugby group was compared with 33 age- and sex-matched healthy controls with no evidence of previous head trauma or dementia onset. Participants were 90% male. The median rugby career lasted 10.5 years, with 63% playing as forwards and 37% as backs. Mental Health and Behavioural Symptoms The former players scored higher on self-rated scales of depression, anxiety, and post-concussion symptoms than those in the control group, though not on sleep quality. These symptoms, along with behaviour ratings of executive dysfunction and neuropsychiatric symptom severity, were more prevalent among individuals who had experienced a greater number of self-reported concussions. However, this was unrelated to the number of years played, or position of play. Despite frequent subjective memory complaints, the performance of players in cognitive testing did not differ significantly from that of the control group. However, 24 former players, particularly those who had played as forwards and those who had reported more concussions, met the research criteria for CTE syndrome based on neurobehavioural disturbance. This was determined with low provisional levels of certainty: 21 were classed as 'suggestive.' three as 'possible.' and none as 'probable/definite.' Seven of the 24 had cognitive impairment, 12 had neurobehavioral dysregulation, and five had both. Imaging Findings 3T MRI imaging showed the presence of cavum septum pellucidum in 24% of players, compared with 12% of controls. This was more common in those who had experienced more concussions. They also showed reduced volumes in the frontal and cingulate cortices, with reduced white matter and lower hippocampal volume associated with longer career durations. Only 4.6% showed trauma-associated white matter changes on diffusion tensor imaging. Elevated Blood Biomarkers Using ultrasensitive digital enzyme-linked immunosorbent assays, researchers analysed fluid biomarkers associated with neurodegeneration. Key findings included: Phospho-tau217 levels were 17.6% higher in former players 23.1% had elevated phospho-tau217 9.0% had raised plasma neurofilament light While levels were lower than in late-onset Alzheimer's patients, players with elevated markers had more severe neuropsychiatric symptoms, including depression and anxiety. Frontal brain volumes correlated negatively with neurofilament light, and hippocampal volumes correlated negatively with phospho-tau217. The findings were published simultaneously in two papers in the journal Brain . Professor David Sharp, director of the UK Dementia Research Institute Centre for Care Research & Technology at ICL, who co-led the work, said: 'We didn't see any cases of early dementia in this group of former players, which is reassuring. However, the changes in blood biomarkers and brain imaging abnormalities show some long-term effects of repeated head impacts on the brain.' The studies are set to continue for a further 4 years. Calls for Action on Player Safety 'Nearly half of dementia cases are linked to known health and lifestyle risk factors, including traumatic brain injury from contact sports like rugby,' said Dr Jacqui Hanley, head of research at Alzheimer's Research UK. While not much is known about how such injuries cause changes to the brain, 'deepening our understanding could ultimately help lower dementia risk for professional sportspeople.' Hanley called for stronger efforts to reduce head injury in contact sports, stating: 'Reducing traumatic brain injury in contact sports is critical to help prevent brain damage and minimise dementia risk for the players.' The Alzheimer's Society echoed the concern, noting that professional rugby players face approximately twice the risk of dementia. They called for accurate data on injury patterns and their long-term effects. However, they also stressed that physical activity remains one of the most effective ways to reduce dementia risk. The Dementia Trust has warned that repeated tackles, scrums, and collisions can contribute to CTE among rugby players and noted a rise in early-onset dementia among retired professional players. In 2023, a group of 260 former professionals launched a lawsuit against World Rugby, the Welsh Rugby Union, and the Rugby Football Union. They alleged negligence in failing to protect players from the risk of neurodegenerative diseases.
Yahoo
39 minutes ago
- Yahoo
UK Government reveals 10-year plan for NHS
The UK's Labour Government has revealed its '10-Year Health Plan' for the country's National Health Service (NHS). Speaking at a community health centre in London, Health Secretary Wes Streeting outlined what the plan encompasses. This includes a shift from the NHS being a 'sick service' to one that is preventative – an approach Prime Minister Sir Kier Starmer, who also appeared at the launch in Stratford, said will be achieved with a stronger focus on early diagnosis and screening with the use of technology such as AI. The plan's release follows Chancellor of the Exchequer Rachel Reeves' announcement last month that the NHS is set to receive a £29bn funding boost over the next three years. With £10bn ($13.5bn) of the total NHS funding Reeves announced to be earmarked to bring the 'analogue health system into the digital age', another key shift outlined by Starmer lies in transforming the NHS from an analogue to a 'truly digital' service. A report co-authored by Boston Consulting Group (BCG), Siemens Healthineers, and Imperial College London that was commissioned by the NHS as input to its ten-year plan, forecasts that technology-driven innovation, with a focus on earlier diagnosis, has the potential to impact population outcomes through risk stratification and intervention to 'prevent disease and alleviate burden on the broader healthcare system'. Starmer emphasised that the NHS must seize the 'enormous opportunities' presented by developments in science and technology. The UK Prime Minister said: 'AI technology is an opportunity to make us more human,' clarifying that the introduction of more technology within the NHS would give NHS staff more time to 'do the things that only human beings can do'. Regarding technology, he added that there was 'no reason' the future of the NHS could not be a more app-based service, with greater application of the service's app planned for securing appointments and giving patients easier access to participation in clinical trials. Plans would shift the NHS towards being more of a community service, with the introduction of new community health centres. Calling such venues the 'future of the health service', Starmer said: 'Hospitals will always be important, but disease has changed, and we must change with it. Not only can we do that, we can do it in a way that improves care and convenience for millions of people.' According to the Prime Minister, this shift will help improve patient access to general practitioners (GPs), dentists and other services, including mental health support and smoking cessation clinics in 'every community across the country'. Clive Makombera, partner and head of NHS at RSM UK, an audit, tax, and consulting company, called the 10-Year Plan a 'pivotal moment for the future of the NHS'. He said: 'By embedding digital innovation, shifting care closer to home, and focusing on prevention, the NHS is laying the foundation for a more sustainable, equitable, and patient-centred future. 'Whilst these are the right priorities, delivering them will come with their challenges, even with the new funding that was recently announced.' Makombera cautioned that in achieving the government's aims, it must 'get the basics right' and rebalance resources and funding within the NHS to match its priorities. He continued: 'Shifting from reactive treatment to prevention will only be achievable by making better use of technology, delivering care closer to home and developing new models that centre around accountability. However, the NHS desperately needs more staff with the right skill set, which might require leveraging the expertise of the private healthcare sector. That said, existing workforce shortages in the healthcare system cannot be underestimated.' British Healthcare Trades Association (BHTA) CEO David Stockdale said the BHTA welcomed the plan's shift to community-centric care. "But at its foundation must lie the manufacturers and suppliers of essential medical equipment who enable independent living and timely hospital discharges," Stockdale said. "Without them, this vision simply won't take hold." BMA council chair Dr Tom Dolphin highlighted that the plan must show that the Government 'truly values' clinical leaders in the NHS. Dolphin said: 'The success of the plan, and whether it will improve patients' care and the public's lives, will hinge on whether it genuinely addresses the workforce shortages, and values and empowers professionals on the front line, or just rearranges deck chairs on a sinking ship. 'If this plan is to be as ambitious and transformative as the government would have us believe, it needs the backing of staff and any changes must be implemented in genuine partnership with workers on the frontline.' Association of the British Pharmaceutical Industry (ABPI) CEO Richard Torbett called the plans to boost the NHS's offer on genomic medicine and accelerate clinical trials 'exactly right and very welcome'. 'This will transform patients' lives and take better advantage of the precision medicines and benefits of research that our sector can offer,' Torbett said. 'However, the successful implementation of the NHS 10-Year Plan will require a fundamental shift in how the UK approaches innovative medicines and vaccines. For too long, the UK has viewed innovation as a cost to be avoided, rather than an investment that can improve health outcomes and system productivity. 'The UK must reverse decades of disinvestment in innovative medicines that is increasingly preventing NHS patients from accessing medicines that are available in other countries.' Gerard Hanratty, head of health and life sciences at law company Browne Jacobson, held the banking industry up as one the NHS should take cues from. He said: 'Healthcare can learn much from the banking industry's digital transformation journey, which has been underpinned by consumer acceptance – and enthusiasm – for sharing sensitive data that provides real-time metrics and intelligent insights to manage finances effortlessly. 'Replicating this model to create 'digital health wallets' – secure, user-controlled platforms for storing, managing and sharing health information – could revolutionise patient self-management and open the door to incentivisation initiatives that are fundamental to the move from sickness care to prevention.' Amadeus Capital Partners' Pierre Socha called the NHS' plans to expand access to clinical trials through the NHS app a 'welcome step toward a more predictive, personalised healthcare system'. He commented: 'We've long believed that AI-driven diagnostics are foundational to the future of medicine. By embedding these technologies into national infrastructure, the UK is not only improving patient outcomes but also reinforcing its position as a global leader in life sciences innovation. "The integration of genomic data into routine care, combined with streamlined access to clinical trials via the NHS App, has the potential to accelerate drug development, reduce health inequalities, and unlock new models of preventative care.' "UK Government reveals 10-year plan for NHS" was originally created and published by Hospital Management, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
2 hours ago
- Bloomberg
Summit Is in Talks for $15 Billion Partnership With AstraZeneca
By and Dinesh Nair Save AstraZeneca Plc is discussing a partnership deal with Summit Therapeutics Inc. in which it could pay as much as $15 billion over time to license a lung-cancer drug, according to people familiar with the matter. The companies have been holdings talks regarding the potential partnership over Summit's ivonescimab treatment, the people said, asking not to be identified because that matter is private. Summit has also held discussions with other major pharmaceutical firms, the people said.
